Programme

Royal College of Physicians, London – Monday 27th November 2017

Chairs:
Professor Derek Yellon
Professor of Molecular & Cellular Cardiology, University College London;
Director of the Hatter Cardiovascular Institute at UCL Hospitals & Medical School, London, UK

Professor John Cunningham
Professor of Nephrology, University College London Medical School and The Royal Free Hospital;
Honorary Fellowship, Trinity Hall, University of Cambridge, UK

Dr Richard Horton
Editor-in-Chief, The Lancet, London, UK


Please note that timings are provisional and subject to change.
Monday 27th November - Morning

From 08:00
Badge Collection & Coffee

09:00
The global burden of diabetes
Professor Paul Zimmet
Monash University, Melbourne, Australia

09:40
Therapy for the treatment of type 2 diabetes: out with the old and in with the new?
Professor Naveed Sattar
University of Glasgow, Scotland

10:20
Coffee Break

10:45
The biology and therapeutic potential of GLP-1
Dr Daniel Drucker
University of Toronto, Canada

11:25
The biology and therapeutic potential of SGLT2 inhibition
Professor Bernard Zinman
University of Toronto, Canada

Monday 27th November - Afternoon

12:05
Lunch

13:00
The GLP-1 analogues & DPPIV Inhibitors - cardiovascular outcome benefits for some but not others?
Professor Nikolaus Marx
Aachen University, Germany

13:40
The sodium-glucose co-transporter inhibitors - a cardiologist’s perspective
Professor Lars Rydën
The Karolinska Institute, Stockholm, Sweden

14:20
Sweetening the urine: a new approach to the management of chronic kidney disease
Professor David Wheeler
Royal Free Hospital UCL, London, UK

15:00
Coffee Break

15:25
Let us not forget Metformin!
Professor Cliff Bailey
Aston University, Birmingham, UK

16:05
Combination therapy - the way to go for cardioprotection
Dr Bob Ryder
City Hospital, Birmingham, UK

16:45
Close

The meeting is supported by educational grants and sponsorship from the Pharmaceutical Industry including Novo Nordisk Ltd, Napp Pharmaceuticals Ltd, AstraZeneca, Boehringer Ingelheim, all of whom have provided support for this programme and had no editorial control or influence on the content of the meeting.  Further information can be found here: https://horizonseries.org/hhs-2017/supporters/